Clinical Trial Update: EMPagliflozin After Aortic Valve Replacement [Phase 4]

View source ↗

Summary

Phase 4 trial update for empagliflozin after aortic valve replacement; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Aortic Valve Stenosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING